|Bid||23.75 x 900|
|Ask||23.91 x 900|
|Day's Range||23.70 - 24.75|
|52 Week Range||21.60 - 44.66|
|Beta (5Y Monthly)||1.08|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 25, 2023 - Jul 31, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||30.08|
Subscribe to Yahoo Finance Plus to view Fair Value for TDOCLearn more
If you have an extra $100 lying around, you may not immediately think about investing it in the stock market. Growth stocks are a great idea -- because once the economy improves, they could take off. Teladoc Health (NYSE: TDOC) is a leader in the global telemedicine market, which is growing in the double digits.
Superstar investor Cathie Wood is prepared. Teladoc Health (NYSE: TDOC) is one of Cathie Wood's top 10 holdings in her ARK Genomic Revolution ETF. First, Teladoc, even during last year's tough moments, continued to grow revenue and telemedicine visits in the double digits.
Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In the latest trading session, Teladoc (TDOC) closed at $24.79, marking a +1.27% move from the previous day.
Right now may not be the easiest time for growth stocks. In fact, now is actually the perfect moment to buy growth stocks. Two perfect examples are telemedicine giant Teladoc Health (NYSE: TDOC) and e-commerce company Etsy (NASDAQ: ETSY).
On the other hand, every double-digit percentage decline in the major indexes, including the Nasdaq Composite, has proven to be a buying opportunity for patient investors. Despite never knowing when corrections or bear markets will start, how long they'll last, or how steep the decline will be, history does conclusively show that index-based losses associated with every decline are eventually cleared away by a bull market. For investors with a long-term mindset, this represents an opportunity to pounce on innovative growth stocks trading at a discount.
Teladoc Health (NYSE: TDOC) has provided several bumpy quarters for investors, many of whom have zeroed in on the company's series of multibillion-dollar impairment charges after apparently overpaying for Livongo back in 2020. Revenue rose 11% year over year in the first quarter to $629 million.
Artificial intelligence (AI) is all the rage on Wall Street these days -- and much of the excitement has rightfully centered around leading semiconductor companies. Nvidia's blockbuster first-quarter results and forward guidance have spurred huge gains for its share price and helped trigger an upswing in bullish momentum across the broader market, but Ark Invest CEO Cathie Wood believes that the biggest AI investing opportunity actually lies in software right now. In a May 31 interview with Bloomberg TV, Wood said that here company was looking beyond semiconductor stocks when it comes to capitalizing on revolutionary AI trends.
Regardless of your investing experience or risk tolerance, putting cash into stocks takes a certain tolerance for volatility and uncertainty. Investing in wonderful businesses, diversifying the ones you own, holding onto those great companies through the market's highs and lows, and avoiding traps like market timing can help you outpace the returns of the average retail investor through the years. Pfizer (NYSE: PFE) caught the attention of many investors when it became one of the leading contenders in the race to get a COVID-19 vaccine to market.
Looking for the best growth stocks to buy will take much more scrutiny in the current market environment. I wrote a column on Dec. 31, 2022 about 25 tech stocks to “buy before they take off in 2023.” Almost all of them have rallied and are up substantially since they changed hands for peanuts back then. However, the situation now is very different after the rally this year, and most growth stocks do not provide compelling entry points. This does not mean that investors should shun all growth nam
Amid concerns about inflation and the Federal Reserve’s aggressive rate tightening, market conditions are anticipated to remain difficult in 2023. The ongoing Russian invasion of Ukraine further contributes to the uncertain market outlook. Thus, finding stocks to buy in this environment can seem like a very difficult task. However, there are some high potential stocks for life-changing gains out there. The search for these stocks to buy for huge profits is complicated by valuation multiples whic
No bear market period is exactly alike, and the prolonged volatility of the past year-plus understandably has some investors frustrated. Patience and fortitude are warranted to be a long-term investor, and the current market environment continues to prove that point more than ever. Teladoc Health (NYSE: TDOC) hasn't been the portfolio winner many investors had hoped for over the last year, and shares of the telehealth giant have experienced far more volatility than the average healthcare stock.
Last year may have scared investors away from the stock market. As the market recovers, some growth stocks with strong fundamentals may thrive. Two such revolutionary companies are virtual healthcare leader Teladoc Health (NYSE: TDOC), and robotic surgery leader Intuitive Surgical (NASDAQ: ISRG).
As we can see in the chart below, putting money into the stock market before the recession would have been a wise idea. Earlier, I briefly mentioned the idea of low valuations being a reason to invest.
Cathie Wood's ARK Invest ETFs are on the rebound in 2023 after plunging in 2021 and 2022. Five ARK Invest stocks to watch include Tesla.
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CRISPR Therapeutics (NASDAQ: CRSP) and Teladoc Health (NYSE: TDOC) both score a win when it comes to innovation in healthcare. CRISPR has developed a gene-editing approach that aims to fix faulty genes responsible for disease. Teladoc leads in telemedicine, allowing patients to visit doctors from the comfort of an armchair at home.
Given the market volatility over the past few years, some investors are questioning whether they should still be putting their hard-earned money into the stock market. Let's take a closer look at two excellent growth stocks to buy right now: Teladoc Health (NYSE: TDOC) and DexCom (NASDAQ: DXCM). Last year was a horror show for Teladoc.
These stocks are both trading at lower prices now than the lows they hit during the 2020 market crash.
The good news is you really don't have to -- and you still can win in the stock market. The success of Moderna's (NASDAQ: MRNA) blockbuster coronavirus vaccine helped the stock soar earlier in the pandemic. Here's why they shouldn't: The vaccine represents just the beginning of Moderna's growth story.
Teladoc Health (NYSE: TDOC) stock has been on a crazy ride the past few years, from a high of $308 in February of 2021 to a low of $21.60 this past February. The healthcare company has solid name recognition as an early mover in telehealth. Here are three things that smart investors know about Teladoc.
Billionaire investor Warren Buffett says, "The stock market is a device for transferring money from the impatient to the patient." There are many impatient investors right now dumping shares of companies that have been struggling over the past year or so. Two such examples are PayPal Holdings (NASDAQ: PYPL) and Teladoc Health (NYSE: TDOC).
Cathie Wood looks for stocks that are leading innovators. But the stocks that fit that mold aren't always leaders when it comes to delivering huge returns over the short term. On the contrary, quite a few of the stocks in Wood's Ark Invest portfolios have been big losers.
Teladoc Health's (TDOC) cash-generating abilities are boosted by the growing number of visits and memberships.
A lot has changed for Teladoc Health (NYSE: TDOC) since the company's IPO in 2015. The stock is still reeling from management's dramatic misstep in overpaying for Livongo in 2020. Teladoc spent years as a telehealth company, where patients could meet with healthcare professionals digitally.